Greenberg Traurig’s David J. Dykeman and Roman Fayerberg Present at DeviceTalks Boston

May 11, 2023

Posted by Greenberg Traurig, LLP

BOSTON – May 11, 2023 – David J. Dykeman, co-chair of the Life Sciences & Medical Technology Practice of global law firm Greenberg Traurig, LLP and co-managing shareholder of the firm’s Boston office, and Roman Fayerberg, shareholder of the firm’s Boston office, presented on the DeviceTalks Boston panel, “IP Strategy to Attract Funding & Exits,” May 10. 

The panel focused on how Intellectual Property (IP) is key for medical technology companies to secure funding and exits. Additional panelists include Addie Harris, CEO of Haventure, and Jeremy Sohn, managing general partner at P74 Ventures. The panelists provide insight on creating a strategic and competitive patent portfolio to close funding and secure exits. 

A registered patent attorney with 25 years of experience in patent and IP law, Dykeman focuses his practice on securing worldwide IP protection and related business strategy for high tech clients, with particular experience in life sciences, medical devices, robotics, materials, and information technology. Dykeman provides strategic patent portfolio development and IP advice for clients, including major research institutions, multinational corporations, and early-stage companies. He also performs patent due diligence to assess patent portfolios for venture capital investment, mergers and acquisitions, and licensing opportunities. An author of over 55 articles and a speaker at over 50 conferences on IP law, Dykeman is the founding co-chair of the American Bar Association’s Medical Devices Committee. In 2022, Dykeman was named “Patent Strategy Attorney of the Year for Massachusetts” by LMG Life Sciences.


Fayerberg is a registered patent attorney with broad experience helping clients strategically protect and leverage their innovations globally. He works with clients to develop and manage worldwide patent portfolios and counsels clients regarding freedom to operate, patent landscape, and patent infringement and validity matters. Fayerberg also conducts and defends patent due diligence investigations in connection with venture capital investments, mergers and acquisitions, and licensing opportunities. Fayerberg has represented clients ranging from startups to global companies in a variety of technical areas, including medical devices, robotics, diagnostic and imaging systems, microfluidic devices, and biotechnology.

About Greenberg Traurig’s Life Sciences & Medical Technology Group: Greenberg Traurig’s Life Sciences & Medical Technology Group advises clients ranging from start-ups to large multinational public companies to leading research institutions. The group’s attorneys work closely with clients, providing innovative legal counsel to help them achieve their objectives – from discovery through commercialization and product marketing.


About Greenberg Traurig’s Boston Office: Established in 1999, Greenberg Traurig’s Boston office is home to more than 85 attorneys practicing in the areas of banking and finance, corporate, emerging technology, energy, environmental, gaming, governmental affairs, intellectual property, labor and employment, life sciences and medical technology, litigation, public finance, real estate, restructuring and bankruptcy, tax, and white collar defense and investigations. An important contributor to the firm’s international platform, the Boston office includes a team of nationally recognized attorneys with both public and private sector experience. The team offers clients the value of decades of helping clients in complex legal matters and hands-on knowledge of the local business community, supported by the firm’s vast network of global resources.

About Greenberg Traurig: Greenberg Traurig, LLP has more than 2650 attorneys in 45 locations in the United States, Europe and the Middle East, Latin America, and Asia. The firm is a 2022 BTI “Highly Recommended Law Firm” for superior client service and is consistently among the top firms on the Am Law Global 100 and NLJ 250. Greenberg Traurig is Mansfield Rule 5.0 Certified Plus by The Diversity Lab. The firm is recognized for powering its U.S. offices with 100% renewable energy as certified by the Center for Resource Solutions Green-e® Energy program and is a member of the U.S. EPA’s Green Power Partnership Program. The firm is known for its philanthropic giving, innovation, diversity, and pro bono. Web:

See all Member News